Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 103 participants.

Also called NCT03433274

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03433274
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03433274. Randomized; no masking; primary purpose treatment. Start 2018-06-15 (actual); primary completion 2024-04-29 (actual). Results posted on 2026-01-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Acronym
SUMMIT
Condition
Mitral Regurgitation
Condition
Mitral Insufficiency
Condition
Mitral Valve Insufficiency
Condition
Cardiovascular Diseases
Condition
Valve Disease, Heart
Condition
Heart Valve Diseases
Condition
Functional Mitral Regurgitation
Condition
Degenerative Mitral Valve Disease
Intervention (Device)
Tendyne Mitral Valve System
Intervention (Device)
MitraClip System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct03433274
Content hash
04d9b257ff5fe0fa33bfbc422b52eaa0bfc3e15a6372c7ec07c95fe300d3108c